In these previous studies, PREX2 has been considered as a tumor-promoting gene because of its GEF activity toward Rac GTPase and its inhibition of the tumor suppressor PTEN, a lipid phosphatase that antagonizes PI3K by dephosphorylating PIP3, therefore reducing AKT activation 20-23. Here, PTEN is linked to neoplasm.